Isoniazid Dosage in Patients with Renal Failure
- 12 July 1973
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 289 (2) , 84-87
- https://doi.org/10.1056/nejm197307122890208
Abstract
ALTHOUGH isoniazid has been used in antituberculous therapy for 20 years, the influence of renal failure on isoniazid excretion has never been established. Paradoxically, this gap in medical knowledge continues despite expanded indications for the use of the drug in patients with renal failure. For example, the American Thoracic Society ad Hoc Committee on chemoprophylaxis has included tuberculin-positive patients with a variety of chronic renal diseases in their recommendations for isoniazid prophylaxis.1 In patients with normal renal function 50 to 80 per cent of a dose of isoniazid is excreted in the urine in 24 hours.2 3 4 5 Part of the drug . . .Keywords
This publication has 8 references indexed in Scilit:
- CURRENT CONCEPTS OF THE METABOLISM OF ANTITUBERCULOUS AGENTSAnnals of the New York Academy of Sciences, 2006
- Kinetics of rifampicin and isoniazid administered alone and in combination to normal subjects and patients with liver diseaseGut, 1972
- A practical guide to drug usage in adult patients with impaired renal functionPublished by American Medical Association (AMA) ,1970
- Isoniazid self‐poisoningNeurology, 1970
- A study of the availability of six commercial formulations of isoniazidClinical Pharmacology & Therapeutics, 1969
- GENETIC VARIATIONS IN THE ACETYLATION OF ISONIAZID AND OTHER DRUGSAnnals of the New York Academy of Sciences, 1968
- A Guide to Use of Antibiotics in Patients with Renal DiseaseAnnals of Internal Medicine, 1967
- Genetic Control of Isoniazid Metabolism in ManBMJ, 1960